CAS 64000-73-3

Pildralazine

Description:

Pildralazine is a chemical compound that belongs to the class of hydrazine derivatives, primarily known for its use as an antihypertensive agent. It functions by acting as a vasodilator, helping to lower blood pressure by relaxing blood vessels. The molecular structure of Pildralazine includes a hydrazine moiety, which is characteristic of its pharmacological activity. It is typically administered in a pharmaceutical formulation, and its efficacy is often evaluated in clinical settings for managing hypertension. The compound is known to exhibit a range of biological activities, including potential effects on the cardiovascular system. However, like many pharmacological agents, it may also have side effects and contraindications that need to be considered during treatment. Pildralazine's safety profile and therapeutic applications are subjects of ongoing research, and it is essential for healthcare providers to stay informed about the latest findings related to its use. As with any medication, proper dosage and monitoring are crucial for achieving the desired therapeutic outcomes while minimizing risks.

Formula: C₈H₁₅N₅O

InChI: InChI=1S/C8H15N5O/c1-6(14)5-13(2)8-4-3-7(10-9)11-12-8/h3-4,6,14H,5,9H2,1-2H3,(H,10,11)

InChI key: InChIKey=KYIAWOXNPBANEW-UHFFFAOYSA-N

SMILES: N(CC(C)O)(C)C=1C=CC(=NN)NN1

Synonyms:

• 2-Propanol, 1-[(6-hydrazinyl-3-pyridazinyl)methylamino]-
• 3(2H)-Pyridazinone, 6-[(2-hydroxypropyl)methylamino]-, hydrazone
• Pildralazine
• 1-[(6-Hydrazinyl-3-pyridazinyl)methylamino]-2-propanol
• Propyldazine

Pildralazine

CAS: 64000-73-3

Pildralazine, also Propyldazine, is an oral, non-carcinogenic antihypertensive vasodilator similar to hydralazine.

Formula: C₈H₁₅N₅O

Color and Shape: Solid

Molecular weight: 197.24

Ref: TM-T72914